INDOCOBSEINDOCO REMEDIES LTD.· PharmaceuticalsMinimalNeutral
Announced Wed, 28 Oct, 2026 · 13:47 IST

Indoco quarterly net profit Rs 30.63 crore standalone, Rs 19.47 crore consolidated

INDOCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.3%Reaction day
₹219.20
prior close
₹215.05
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending
Pharmaceuticals peers, median of 170sector+0.6%-2.8% vs sector

On the reaction day the stock moved 2.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
+0.1
15m
-0.2
30m
-0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.3pendingpending+0.6-2.8
Next day
—————
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indoco published unaudited quarter and half-year results for the period ended 30 September 2026. September quarter: standalone revenue Rs 451.59 crore, net profit Rs 30.63 crore; year-ago revenue Rs 442.12 crore, profit Rs 15.05 crore. Consolidated revenue Rs 520.17 crore, net profit Rs 19.47 crore; year-ago revenue Rs 484.67 crore, loss Rs 9.21 crore. Six-month net profit: Rs 112.95 crore standalone, Rs 84.92 crore consolidated. Profit before exceptional items was negative.

Likely market impact

Profit rose and prior-year losses reversed, which may support the stock. However, losses excluding exceptional gains show weak underlying operations.